Citation: Ks. Kim et al., Inhibition of aminopeptidase P potentiates wheal response to bradykinin inangiotensin-converting enzyme inhibitor-treated humans, J PHARM EXP, 292(1), 2000, pp. 295-298
Authors:
Kitamura, S
Carbini, LA
Simmons, WH
Scicli, AG
Citation: S. Kitamura et al., Effects of aminopeptidase P inhibition on kinin-mediated vasodepressor responses, AM J P-HEAR, 45(5), 1999, pp. H1664-H1671
Authors:
Blais, C
Marc-Aurele, J
Simmons, WH
Loute, G
Thibault, P
Skidgel, RA
Adam, A
Citation: C. Blais et al., Des-Arg(9)-bradykinin metabolism in patients who presented hypersensitivity reactions during hemodialysis: role of serum ACE and aminopeptidase P, PEPTIDES, 20(4), 1999, pp. 421-430
Citation: C. Ersahin et al., Cardioprotective effects of the aminopeptidase P inhibitor apstatin: Studies on ischemia/reperfusion injury in the isolated rat heart, J CARDIO PH, 34(4), 1999, pp. 604-611
Citation: Ll. Maggiora et al., Apstatin analogue inhibitors of aminopeptidase P, a bradykinin-degrading enzyme, J MED CHEM, 42(13), 1999, pp. 2394-2402